Fosun Pharmaceuticals announced that on July 21, 2026, the controlling shareholder Fosun Hi-Tech released its pledge of 69 million A shares, accounting for 7.18% of the company's shares and 2.58% of the total number of shares in the company. As of the close of the day, Fosun Hi-Tech held 961,424,455 shares of the company, accounting for 36.00%. The balance of pledged shares was 523,275,000 shares, accounting for 19.60% of the total number of shares in the company. Fosun Hi-Tech and its co-actors held a total of 967,812,180 shares of the company, accounting for 36.24%. The balance of pledged shares was 523,275,000 shares, accounting for 54.07% of the company's shares. Shares that have been released from pledge this time have subsequent pledge plans.

Fosun Pharmaceuticals announced that on July 21, 2026, the controlling shareholder Fosun Hi-Tech released its pledge of 69 million A shares, accounting for 7.18% of the company's shares and 2.58% of the total number of shares in the company. As of the close of the day, Fosun Hi-Tech held 961,424,455 shares of the company, accounting for 36.00%. The balance of pledged shares was 523,275,000 shares, accounting for 19.60% of the total number of shares in the company. Fosun Hi-Tech and its co-actors held a total of 967,812,180 shares of the company, accounting for 36.24%. The balance of pledged shares was 523,275,000 shares, accounting for 54.07% of the company's shares. Shares that have been released from pledge this time have subsequent pledge plans.